Spero therapeutics to present at three upcoming investor conferences

Cambridge, mass., sept. 07, 2021 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that ankit mahadevia, m.d., president and chief executive officer of spero therapeutics, will present and be available for virtual one-on-one meetings at the h.c. wainwright 23rd annual global investment conference, the oppenheimer fall healthcare life sciences & medtech summit, and the 2021 cantor virtual global healthcare conference, taking place virtually september 13 – 15th, 2021, september 20 – 23rd, 2021, and september 27 – 30th, 2021, respectively.
SPRO Ratings Summary
SPRO Quant Ranking